Safety Data SheetChemical Risk Assessment

Crizotinib Capsules

by Pfizer Ltd

SDS · PDF, approx. 220 KB CRA · PDF, approx. 180 KB

Crizotinib Capsules is supplied by Pfizer Ltd under product code XALKORI, CRIZALK. This page provides both the Safety Data Sheet (SDS) and the Chemical Risk Assessment (CRA) for this substance, under OSHA regulations for UK workplace use under COSHH. The full SDS and CRA documents are available to download above.

This SDS was last revised on 8 February 2018. The matching CRA is updated in line with SDS revisions. Workplaces handling this substance should retain a current SDS and risk assessment for the duration of use.


Language
English
Regulation
OSHA
Revision Date
08 Feb 2018
Signal Word
DANGER
Product Code
XALKORI, CRIZALK
CAS Number
877399-52-5,7757-93-9,9004-34-6,557-04-0,1309-37-1,13463-67-7,9063-38-1,9000-70-8

Switch between the Safety Data Sheet and the Chemical Risk Assessment for this substance.

Hazards at a GlanceFrom the Safety Data Sheet
Signal Word: DANGER

Health hazardGHS08Health hazard
Harmful / irritantGHS07Harmful / irritant
EnvironmentGHS09Environment
CorrosiveGHS05Corrosive
Hazard Statements (H-phrases)
H318
Causes serious eye damage.
H317
May cause an allergic skin reaction.
H341
Suspected of causing genetic defects.
H400
Very toxic to aquatic life.

Need the full hazard breakdown? Precautionary statements, first aid, physical properties and exposure controls are in the full SDS PDF.


Common QuestionsAbout this Safety Data Sheet

Need help with Safety Data Sheets? You've come to the right place!

CONTACT US